Globus Medical, Inc. Financial Ratios — GMED Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	40.11	34.53	24.07	25.3	24.09	18.09	15.72	19.21	15.99	9.77	13.32	15.62	10.34	8.99	42.33
Return on Assets (%)	20.4	19.02	13.54	14.57	14.67	11.85	10.7	13.15	10.96	6.37	8.2	9.43	3.43	1.99	10.19
Return on Capital (%)	39.42	34.5	23.96	25.15	23.9	17.74	15.11	17.86	14.53	9.77	13.32	15.58	8.46	6.15	33.65
Return on Invested Capital (%)	24.04	21.96	19.45	17.92	16.38	13.55	11.59	13.59	11.16	6.45	9.91	10.26	4.68	4.03	10.12
Gross Margin (%)	79.25	80.52	76.9	76.65	75.71	76.12	76.34	77.64	77.08	72.44	75.03	74.22	65.05	58.9	67.41
EBITDA Margin (%)	34.93	34.23	33.17	34.75	34.58	35.09	32.73	30.65	29.22	22.6	27.63	29.77	22.12	18.77	27.7
Operating Margin (%)	29.82	29.54	28.71	30.16	30.16	28.21	26.12	24.81	22.51	14.63	20.34	23.1	12.84	8.71	18.28
Incremental Operating Margin (%)	19.31	27.84	22.12	46.01	30.14	-26.94	9.72	13.98	-0.18	-1,667.99	46.96	63.94	-6.38	1.89	75.74
Pretax Margin (%)	29.25	29.7	23.48	29.23	31.72	27.89	26.72	26.45	24.19	15.96	18.83	23.76	10.54	4.79	20.59
Profit Margin (%)	18.34	19.13	15.79	19.5	20.7	18.5	16.88	21.95	19.76	12.96	15.57	18.59	7.83	4.09	18.3
Net Income to Common Margin (%)	18.34	19.13	15.79	19.5	20.7	18.5	16.88	21.95	19.76	12.96	15.57	18.59	7.83	4.09	18.3
Effective Tax Rate (%)	37.3	35.6	32.73	33.29	34.73	33.66	36.83	17.04	18.29	18.76	17.3	21.75	25.71	14.69	11.11
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	40.11	34.53	24.07	25.3	24.09	18.09	15.72	19.21	15.99	9.77	13.32	15.62	10.34	8.99	42.33

Credit (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	520	537	119
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	12	454	15
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	508	84	104
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.02	1.5	1.14	0.15
Net Debt/EBITDA	-1.23	-1.61	-0.62	-0.5	-0.32	-0.34	-0.57	-0.64	-0.85	-1.34	-0.73	-0.49	-0.14	-0.72	-0.65
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.03	2.58	2.45	0.22
Net Debt/EBIT	-1.44	-1.86	-0.72	-0.57	-0.37	-0.42	-0.72	-0.79	-1.11	-2.07	-0.99	-0.64	-0.25	-1.55	-0.98
EBITDA to Interest Expense	- -	-1,651.44	-308.62	-204.78	-144.47	-64.73	-31.51	-16.46	-13.18	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	-1,342.89	-257.91	-174.03	-105.54	-51.35	-23.74	-11.96	-9.12	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	-1,425.09	-267.08	-177.75	-126	-52.05	-25.14	-13.32	-10.15	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	-1	-1	-3	-7	-13	-17	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	53.71	56.08	56.4	58.54	62.9	67.81	68.27	68.64	68.41	62.23	61.02	59.73	22.36	21.95	26.18
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.19	12.72	2	2.27
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.28	30.67	4.95	6.9
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.17	10	1.59	1.96
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.33	13.02	12.86	2.59
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.48	31.39	31.78	7.87
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.29	10.23	10.23	2.24
Net Debt to Equity	-50.51	-54.95	-19.05	-14.05	-8.41	-8.05	-12.28	-11.78	-13.96	-15.89	-11.09	-8.15	-1.25	-8.17	-11.51
Net Debt/Capital (%)	-415.92	-553.59	-39.21	-24.96	-12.95	-11.91	-19.24	-18.54	-22.96	-29.71	-19.28	-13.73	-4.19	-37.66	-53.66
EBITDA	116	132	144	165	188	198	208	219	229	178	265	305	347	473	814
EBITDA-CapEx	93	107	120	140	138	157	157	159	159	115	208	230	269	357	640
Operating Income (Loss)	99	114	125	143	164	159	166	177	177	115	195	236	201	219	537

Liquidity (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	4.87	5.38	3.52	2.56	3.4	3.63	4.02	3.53	2.8	3.53	3.16	2.8	1.32	1.04	1.12
Current Ratio	8.84	9.11	6.13	5.26	6.59	6.43	6.67	6.56	6.17	6.8	6.17	6.18	4.88	2.54	4.26
Quick Ratio	6.58	6.86	4.48	3.47	4.44	4.83	5.38	5.03	4.25	4.76	4.35	4.17	2.61	1.72	2.61
CFO/Avg Current Liab	2.51	2.23	1.74	1.01	1.44	1.82	1.84	1.92	1.66	1.71	2.12	1.19	0.88	0.83	1.11
Common Equity/Total Assets	53.71	56.08	56.4	58.54	62.9	67.81	68.27	68.64	68.41	62.23	61.02	59.73	22.36	21.95	26.18
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.19	12.72	2	2.27
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.28	30.67	4.95	6.9
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.17	10	1.59	1.96
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.33	13.02	12.86	2.59
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.48	31.39	31.78	7.87
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.29	10.23	10.23	2.24
CFO/Total Liabilities	162.87	126.2	99.5	67.04	104.4	154.69	143.65	157.74	132.67	114.78	127.98	77.68	22.38	48.46	103.28
CFO/CapEx	3.4	3.1	3.95	3.2	2.44	3.61	3.1	3.04	2.43	3.12	4.86	2.41	3.11	4.51	4.32
Altman's Z-Score	3.78	12.85	15.24	14.59	16.71	18.18	24.69	25	29.69	24.69	22.64	21.98	5.4	8.4	12.47

Working Capital (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	7.44	7.7	7.5	6.88	7.12	6.65	6.1	5.62	5.39	5.33	6.26	5.42	4.38	4.75	4.75
Days Sales Outstanding	49.09	47.39	48.69	53.03	51.29	54.9	59.88	64.95	67.71	68.46	58.31	67.39	83.37	76.85	76.79
Inventory Turnover	1.56	1.37	1.51	1.37	1.35	1.24	1.36	1.33	1.1	1.02	1.03	0.98	0.96	1.37	1.35
Days Inventory Outstanding	234.11	266.18	241.28	265.75	270.59	295.28	268.2	274.38	332.16	357.06	355.62	370.9	381.9	265.67	270.28
Accounts Payable Turnover	10.95	9.46	8.58	7.73	7.88	8.5	6.88	7.16	9.7	11.69	12.3	11.22	23.66	12.85	12.16
Accounts Payable Turnover Days	33.33	38.57	42.56	47.22	46.34	42.94	53.08	51	37.62	31.22	29.66	32.53	15.43	28.41	30.01
Cash Conversion Cycle	249.86	275	247.41	271.55	275.54	307.24	275	288.33	362.26	394.3	384.27	405.76	449.84	314.11	317.06
Inventory to Cash Days	-185.02	-218.79	-192.59	-212.71	-219.29	-240.38	-208.32	-209.43	-264.45	-288.6	-297.31	-303.52	-298.54	-188.82	-193.49
Inventories	47	62	70	91	105	113	108	131	196	229	237	299	848	659	759
Raw Materials	2	2	1	9	12	13	20	21	33	40	42	60	103	122	162
Work In Process	2	2	3	2	7	11	10	13	16	16	17	19	37	46	64
Finished Goods	43	58	66	80	86	89	78	97	147	173	178	220	707	491	533
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	940	1,870	2,240	2,644	2,373	3,956	4,236	5,838	6,429	7,273	7,462	6,026	11,226	11,806
- Cash & Cash Equivalents	143	212	90	82	60	67	119	140	196	239	193	150	467	784	526
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	520	537	119
Enterprise Value	-143	728	1,631	2,011	2,363	2,083	3,582	3,897	5,526	6,003	6,830	7,022	6,029	10,873	11,367
Total Capital	177	251	319	412	525	629	736	893	1,048	1,045	1,194	1,246	1,658	1,690	1,507
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.48	31.39	31.78	7.87
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.09	0.05	0.01
EV/Sales	- -	1.88	3.75	4.24	4.34	3.69	5.63	5.47	7.04	7.61	7.13	6.86	3.84	4.32	3.87
EV/EBITDA	- -	5.51	11.31	12.2	12.54	10.52	17.21	17.83	24.08	33.66	25.8	23.06	17.38	23	13.96
EV/EBIT	- -	6.38	13.07	14.05	14.38	13.09	21.56	22.03	31.27	51.98	35.05	29.72	29.93	49.56	21.16
EV/Cash Flow to Firm	- -	9.51	17.5	25.57	19.19	14.29	23.13	22.84	35.03	30.2	24.72	39.34	24.76	20.88	15.09
EV/Free Cash Flow to Firm	- -	7.19	13.96	19.45	13.59	11.16	17.37	16.92	24.19	22.87	20.5	27.81	18.74	17.09	12.25
Diluted Market Cap	- -	967	1,901	2,269	2,673	2,392	4,023	4,385	6,006	6,585	7,482	7,623	6,109	11,403	11,966
Diluted Enterprise Value	-143	755	1,811	2,187	2,613	2,326	3,904	4,245	5,810	6,346	7,289	7,479	6,162	11,155	11,559
EV per Share	- -	8.12	17.6	21.34	24.86	21.77	37.22	39.81	55.74	60.89	67.8	69.89	53.31	80.11	84.07
TTM Sales	331	386	434	474	545	564	636	713	785	789	958	1,023	1,568	2,519	2,939
TTM EBITDA	116	132	144	165	188	198	208	219	229	178	265	305	347	473	814
TTM Operating Income	99	114	125	143	164	159	166	177	177	115	195	236	201	219	537
TTM Cash Flow to Firm	76	76	93	79	123	146	155	171	158	199	276	178	243	521	753
TTM Free Cash Flow to Firm	99	101	117	103	174	187	206	230	229	262	333	253	322	636	928

Multiples (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	9.56	16.23	21.83	15.29	12.68	19.13	18.17	24.74	25.09	22.46	30.19	18.98	17.93	12.9
EV/EBIT	- -	6.38	13.07	14.05	14.38	13.09	21.56	22.03	31.27	51.98	35.05	29.72	29.93	49.56	21.16
Enterprise Value	-143	728	1,631	2,011	2,363	2,083	3,582	3,897	5,526	6,003	6,830	7,022	6,029	10,873	11,367
Low Price	- -	10.26	10.55	17.45	20.48	19.25	24.58	41.19	38.01	33.41	59.36	52.6	43.38	49.33	51.79
EV/Sales	- -	1.88	3.75	4.24	4.34	3.69	5.63	5.47	7.04	7.61	7.13	6.86	3.84	4.32	3.87
EV/EBITDA	- -	5.51	11.31	12.2	12.54	10.52	17.21	17.83	24.08	33.66	25.8	23.06	17.38	23	13.96
Price/Earnings	- -	12.73	27.25	24.22	23.44	22.74	36.85	27.07	37.61	62.86	48.75	39.24	49.05	109.01	21.95
Price/Earnings Average	- -	17.9	21.92	23.06	21.1	21.69	27.86	31.56	30.47	49.84	48.57	34.79	51.92	86.86	17.6
Price/Earnings High	- -	24.19	27.34	27.65	24.43	25.34	37.66	36.18	38.42	64.24	56.87	43.21	73.67	114.95	23.86
Price/Earnings Low	- -	12.45	14.25	17.78	17.26	17.65	22.04	25.77	24.28	32.2	40.08	27.79	39.93	65.01	13.02
Price/Book Value	- -	3.75	5.85	5.44	5.04	3.77	5.37	4.74	5.57	6.15	6.09	6.02	5.3	9.74	8.5
Price/Book Value Average	- -	5.27	4.71	5.18	4.54	3.6	4.06	5.53	4.51	4.88	6.07	5.34	5.61	7.76	6.82
Price/Book Value High	- -	7.12	5.87	6.21	5.25	4.2	5.49	6.34	5.69	6.29	7.1	6.63	7.96	10.27	9.25
Price/Book Value Low	- -	3.67	3.06	3.99	3.71	2.93	3.21	4.52	3.6	3.15	5.01	4.26	4.31	5.81	5.04
Price/Tangible Book Value	- -	2.6	4.4	4.5	4.48	3.57	5.17	4.35	4.89	5.09	4.87	4.71	3.68	5.76	4.93
Price/Tangible Book Value Average	- -	3.66	3.54	4.28	4.03	3.41	3.91	5.07	3.96	4.04	4.85	4.17	3.89	4.59	3.96
Price/Tangible Book Value High	- -	4.94	4.42	5.14	4.67	3.98	5.28	5.81	4.99	5.2	5.68	5.18	5.52	6.07	5.36
Price/Tangible Book Value Low	- -	2.54	2.3	3.3	3.3	2.77	3.09	4.14	3.15	2.61	4.01	3.33	2.99	3.43	2.93
Price/Sales	- -	2.44	4.3	4.72	4.85	4.21	6.22	5.94	7.43	8.15	7.59	7.3	3.84	4.46	4.02
Price/Sales Average	- -	3.42	3.46	4.5	4.37	4.01	4.7	6.93	6.02	6.46	7.56	6.47	4.07	3.55	3.22
Price/Sales High	- -	4.63	4.32	5.39	5.06	4.69	6.36	7.94	7.59	8.33	8.86	8.03	5.77	4.7	4.37
Price/Sales Low	- -	2.38	2.25	3.47	3.57	3.26	3.72	5.66	4.8	4.17	6.24	5.17	3.13	2.66	2.38
Price/Cash Flow	- -	12.28	20	28.29	21.32	16.05	24.87	23.32	33.95	32.34	26.33	41.81	24.75	21.56	15.67
Price/Cash Flow Average	- -	17.27	16.09	26.93	19.19	15.31	18.8	27.19	27.5	25.64	26.23	37.07	26.2	17.18	12.57
Price/Cash Flow High	- -	23.34	20.07	32.29	22.22	17.88	25.41	31.16	34.68	33.05	30.71	46.04	37.17	22.74	17.04
Price/Cash Flow Low	- -	12.02	10.46	20.77	15.7	12.46	14.87	22.2	21.91	16.57	21.65	29.61	20.15	12.86	9.29
Price/Free Cash Flow Average	- -	13.44	13.05	20.79	13.76	12.09	14.46	21.18	20.04	19.89	22.37	26.77	20.1	14.29	10.34
Price/Free Cash Flow High	- -	18.16	16.28	24.92	15.94	14.12	19.54	24.28	25.28	25.64	26.2	33.24	28.51	18.9	14.02
Price/Free Cash Flow Low	- -	9.35	8.48	16.03	11.26	9.84	11.44	17.29	15.97	12.85	18.46	21.38	15.46	10.69	7.65
EV/Sales Average	- -	2.87	3.25	4.32	4.26	3.89	4.52	6.73	5.77	6.16	7.36	6.33	4.1	3.45	3.08
EV/Sales High	- -	4.08	4.11	5.22	4.95	4.57	6.17	7.74	7.34	8.02	8.65	7.89	5.8	4.6	4.23
EV/Sales Low	- -	1.83	2.04	3.29	3.46	3.15	3.53	5.46	4.55	3.87	6.04	5.03	3.16	2.56	2.24
EV/EBITDA Average	-1.23	8.4	9.81	12.44	12.31	11.1	13.8	21.96	19.75	27.24	26.64	21.25	18.54	18.4	11.13
EV/EBITDA High	-1.23	11.91	12.39	15.01	14.31	13.02	18.85	25.27	25.13	35.5	31.32	26.51	26.24	24.52	15.27
EV/EBITDA Low	-1.23	5.35	6.16	9.48	10.01	8.97	10.79	17.81	15.57	17.12	21.86	16.88	14.29	13.64	8.1
EV/EBIT Average	-1.44	9.73	11.33	14.33	14.12	13.8	17.29	27.13	25.64	42.07	36.2	27.39	31.93	39.65	16.87
EV/EBIT High	-1.44	13.8	14.32	17.29	16.4	16.19	23.62	31.21	32.63	54.83	42.55	34.17	45.2	52.83	23.14
EV/EBIT Low	-1.44	6.2	7.12	10.92	11.48	11.15	13.53	22	20.21	26.45	29.7	21.76	24.62	29.39	12.28
Last Price	- -	10.49	20.18	23.77	27.82	24.81	41.1	43.28	58.88	65.22	72.2	74.27	53.29	82.71	87.31
High Price	- -	19.93	20.25	27.14	28.99	27.64	42	57.83	60.15	66.65	84.23	81.78	80.04	87.22	94.93
Enterprise Value Average	-143	1,109	1,414	2,050	2,319	2,196	2,872	4,799	4,533	4,858	7,053	6,471	6,432	8,698	9,061
Enterprise Value High	-143	1,573	1,786	2,475	2,695	2,577	3,923	5,521	5,768	6,331	8,292	8,072	9,105	11,591	12,428
Enterprise Value Low	-143	707	887	1,562	1,886	1,774	2,247	3,892	3,573	3,054	5,787	5,140	4,959	6,448	6,595

Shares Outstanding	90	91	93	95	95	96	97	99	100	100	102	100	136	137	113
Diluted Weighted Avg Shares	75	92	94	95	96	96	98	101	102	101	104	103	115	138	137
Basic Weighted Avg Shares	73	90	93	94	95	96	96	98	99	99	101	100	113	136	135
Revenue per Share	4.56	4.31	4.69	5.03	5.73	5.9	6.61	7.28	7.92	8	9.51	10.18	13.87	18.56	21.74
EBITDA per Share	1.59	1.47	1.56	1.75	1.98	2.07	2.16	2.23	2.31	1.81	2.63	3.03	3.07	3.48	6.02
Operating Income per Share	1.36	1.27	1.35	1.52	1.73	1.66	1.73	1.81	1.78	1.17	1.93	2.35	1.78	1.62	3.97
Basic EPS, GAAP	0.84	0.82	0.74	0.98	1.19	1.09	1.12	1.6	1.57	1.04	1.48	1.89	1.09	0.76	3.98
Basic EPS from Cont Ops	0.84	0.82	0.74	0.98	1.19	1.09	1.12	1.6	1.57	1.04	1.48	1.89	1.09	0.76	3.98
Diluted EPS, GAAP	0.81	0.8	0.73	0.97	1.17	1.08	1.1	1.54	1.52	1.01	1.44	1.85	1.07	0.75	3.92
Diluted EPS from Cont Ops	0.81	0.8	0.73	0.97	1.17	1.08	1.1	1.54	1.52	1.01	1.44	1.85	1.07	0.75	3.92
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	1.05	0.85	1.01	0.84	1.3	1.55	1.65	1.86	1.73	2.02	2.74	1.78	2.15	3.84	5.57
Free Cash Flow per Basic Share	0.74	0.58	0.75	0.58	0.77	1.12	1.12	1.25	1.02	1.37	2.18	1.04	1.46	2.99	4.28
Cash & Equivalents per Share	1.96	2.37	2.58	2.43	2.96	3.04	3.88	3.47	3.14	4.33	4.4	4.44	4.58	6.56	4.12
Book Value per Share	2.43	2.8	3.45	4.37	5.52	6.58	7.65	9.12	10.57	10.6	11.86	12.34	10.06	8.49	10.27
Tangible Book Value per Share	3.65	4.03	4.58	5.28	6.21	6.95	7.95	9.96	12.05	12.81	14.82	15.78	14.49	14.37	17.7

Globus Medical, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)